Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 62,579,000 | 63,627,000 | 59,553,000 | 101,175,000 | 81,288,000 |
| Cost of Goods | 16,067,000 | 17,851,000 | 24,954,000 | 34,344,000 | 30,821,000 |
| Gross Profit | 46,512,000 | 45,776,000 | 34,599,000 | 66,831,000 | 50,467,000 |
| Operating Expenses | 32,268,000 | 33,365,000 | 33,320,000 | 31,042,000 | 31,034,000 |
| Operating Income | 14,244,000 | 12,411,000 | 1,279,000 | 35,789,000 | 19,433,000 |
| Other Income | -6,724,000 | -4,388,000 | -221,000 | -1,060,000 | 4,878,000 |
| Pre-tax Income | 7,520,000 | 8,023,000 | 1,058,000 | 34,729,000 | 24,311,000 |
| Income Tax | -266,000 | -28,000 | -1,115,000 | 3,328,000 | 1,852,000 |
| Net Income Continuous | 7,787,000 | 8,051,000 | 2,172,000 | 31,401,000 | 22,459,000 |
| Net Income Discontinuous | 25,000 | 11,000 | -15,000 | 6,000 | -434,000 |
| Minority Interests | 41,000 | 31,000 | 39,000 | 35,000 | 45,000 |
| Net Income | $7,771,000 | $8,031,000 | $2,119,000 | $31,372,000 | $21,980,000 |
| EPS Basic Total Ops | 1.37 | 1.42 | 0.38 | 5.59 | 3.92 |
| EPS Basic Continuous Ops | 1.37 | 1.42 | 0.38 | 5.59 | 4.00 |
| EPS Basic Discontinuous Ops | 0.00 | 0.00 | 0.00 | 0.00 | -0.08 |
| EPS Diluted Total Ops | 1.36 | 1.41 | 0.37 | 5.47 | 3.85 |
| EPS Diluted Continuous Ops | 1.36 | 1.41 | 0.37 | 5.47 | 3.93 |
| EPS Diluted Discontinuous Ops | 0.00 | 0.00 | 0.00 | 0.00 | -0.08 |
| EPS Diluted Before Non-Recurring Items | 3.22 | 3.11 | 1.84 | 6.58 | 4.42 |
| EBITDA(a) | $20,836,000 | $19,424,000 | $7,569,000 | $40,853,000 | $24,624,000 |